Form 4: Longeveron CFO Lisa Locklear Receives 250k RSU Grant
Statement of Changes in Beneficial Ownership
Longeveron Inc. CFO Lisa Locklear was granted 250,000 time-based restricted stock units as part of an equity compensation award.
Summary
- CFO Lisa Locklear acquired 250,000 shares of Class A Common Stock via a Restricted Stock Unit (RSU) grant.
- The transaction occurred on May 1, 2026.
- Following this grant, the reporting person's total beneficial ownership increased to 465,686 shares.
- The shares were acquired at a price of $0, representing an equity incentive award.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is a routine corporate governance event.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Retention of key financial leadership through time-based vesting incentives.
Negatives
- Potential for future shareholder dilution upon the vesting and settlement of the RSU awards.
Risks
- Market volatility affecting the future value of equity compensation.
- Dependence on the company's ability to meet vesting conditions for the RSU awards.
Future Outlook
The filing does not provide specific forward-looking financial guidance, focusing solely on the disclosure of executive equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the biotechnology sector to ensure leadership retention and align management incentives with clinical and commercial milestones.
Comparison to Industry Standards
- The use of time-based RSU grants is consistent with standard executive compensation packages for small-cap biotech firms.
- The grant size is commensurate with typical CFO compensation structures in the regenerative medicine industry.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual vesting and issuance of the underlying shares.
Next Steps
- Vesting of the granted RSUs according to the company's internal equity incentive plan.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Date of the RSU grant transaction. |
| 05/05/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Longeveron, LGVN, CFO, Insider Trading, Equity Compensation, RSU, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.